Suspected Anaphylaxis Following First Dose of XYZ-mab: A Case Report
We describe an immediate hypersensitivity reaction post-administration of a monoclonal antibody with positive dechallenge.
DSR publishes rapid, rigorously reviewed drug safety case reports, pharmacovigilance analyses, and risk communication. We welcome reports on small molecules, biologics, vaccines, and advanced therapies.
DSR focuses on adverse event case reports, post-marketing safety observations, safety signal detection, medication error reports, risk minimization strategies, and benefit–risk evaluations.
Safety information should be globally accessible to clinicians, regulators, and patients. All articles are free to read and reuse with attribution.
| License | CC BY 4.0 |
|---|---|
| Preprints | Encouraged; cite DOI/version |
| Data | Share anonymized data when possible |
| Code | Provide repositories or appendices |
Processing Charge (APC): TBD (waivers available for low- and middle-income countries).
Single-anonymous by default with optional open reviews. Editorial decisions are based on methodological soundness and clarity.
Planned: DOAJ, Google Scholar, Crossref DOI registration. Early articles receive DOIs upon acceptance.
Browse volumes and issues. Click an issue to view its table of contents.
The table of contents for the selected issue will appear here.
Replace the placeholders below with real content or wire this section to your backend.
We describe an immediate hypersensitivity reaction post-administration of a monoclonal antibody with positive dechallenge.
An analysis of FAERS identifies a disproportionality signal suggesting a potential association requiring further study.
We report a dosing confusion event and propose labeling and EHR safeguards to prevent recurrence.
For inquiries and proposals: editor@openfreescience.com